News on Bluemong

Estrella Immunopharma Initiates Second Cohort and Doses First Patient in STARLIGHT-1 Trial of EB103 in Advanced B-Cell Non-Hodgkin’s Lymphomas http://dlvr.it/TL37C5

http://dlvr.it/TL37C5

1 yr. ago

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from News , click on at the bottom under it

Sign in

No replys yet!